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Summary 
Proper assembly of the class I heavy chain (HC), ~2-microglobulin (~2m),  and peptide must 
occur in the endoplasmic reticulum (ER) in order for MHC class I molecules to be expressed 
on the cell surface. Newly synthesized class I HC bind calnexin, an ER resident chaperone. These 
calnexin-associated  class I  HC  appeared  to lack the stable  association  with ~2m in peptide 
transporter-deficient T2 cells since fl2m-unassociated  class I HC-specific HC10 antibody, but 
not B2m-associated class I HC-specific W6/32  antibody, coimmunoprecipitated calnexin.  To 
determine the precursor-product relationship of the pool of HC that bind peptide, class I-restricted 
peptides were added to lysates of T2 cells in vitro. These peptides stabilized preexisting/32m- 
associated HC complexes (~2m + :HC:pep-), but had no significant effect on the preexisting pool 
of calnexin-associated HC that lack ~2m. Release of HC from calncxin appeared to be controlled 
by the binding of ~2m, since B2m-deficient FO-1 ceils showed a prolonged association of class 
I HC with calnexin,  while fl2m-transfected  FO-1 cells displayed a more rapid dissociation of 
class I HC from calnexin. Consistent with this result, the dissociation of class I HC from calnexin 
did not appear to be dependent on peptide binding since the dissociation rates were similar in 
peptide transporter-deficient T2 cells and in wild-type T1 cells. From these observations,  we 
speculate that in the stepwise assembly of class I molecules, calnexin may mediate dimerization 
of class I HC with fl2m, and that the unstable ~2m + :HC:pep-  complexes,  after dissociation 
from calnexin,  subsequently bind peptide to complete the assembly. 
M 
HC class I molecules present peptide fragments of in- 
tracellular antigens to CD8 + cytotoxic T cells (1, 2). 
Such endogenously synthesized proteins are proteolytically 
degraded into peptides in the cytoplasm and then are trans- 
ported into the endoplasmic reticulum (ER 1) through an 
ER membrane-associated peptide (pep) transporter encoded 
by the TAP.1 and TAP.2 genes (3). The assembly of MHC 
class I heavy chains (HC), 32-microglobulin (32m), and pep- 
tides takes place in the ER (4-6). Mutant cell lines that have 
defects in the assembly of MHC class I molecules, such as 
fl2m-defldent cell lines (R1E in mouse and Daudi in human), 
lack cell surface expression of MHC class I molecules (7, 8). 
Similarly, mice with disruption of the ~zm gene express no 
MHC  class I  molecules and display  a profound defect  in 
CD8 § T cell development (9, 10). In addition, mutant cell 
lines that have deleted the peptide transporter (such as RMA-S 
and .174/T2 cells) appear unable to load peptides onto MHC 
class I molecules in the ER (11-13) and also have a severe 
defect in the expression  of MHC class I molecules on the 
1  Abbreviations used in this paper: Bzm, 32-microglobulin; ER, endoplasmic 
reticulum; HC,  MHC class I heavy chain;  pep,  peptide. 
cell surface. Thus, the complete assembly of MHC class I 
molecules in the ER is an essential step for their cell surface 
expression. 
Studies on the assembly of class I molecules have suggested 
alternative  stepwise  sequences  (14,  15). In  one proposed 
pathway,  the HC can form a loose association  with fl2m, 
which is then stabilized by peptide occupying the binding 
site. Alternatively, a short, high-affinity peptide might stabi- 
lize a conformational change of the HC, which can then as- 
sociate with B2m (16). In either case, the binding of pep- 
tide and ~2m to the HC is cooperative, and peptide binding 
like the association  with B2m is an inherent component of 
class I assembly. Although recombinant or purified compo- 
nents of class I HCs, B2m, and synthesized specific peptides 
can assembly in in vitro buffer systems,  such assembly re- 
quires high concentrations of each component and long periods 
of time to occur (17, 18). Recent evidence has implied that, 
in vivo, molecular chaperones may facilitate protein folding 
and assembly (19), and this may be physiologically relevant 
for class I  assembly in the ER.  Calnexin (IP90,  p88)  was 
identified as an ER resident protein that associates with in- 
completely assembled TCR/CD3, membrane Ig, and MHC 
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tory glycoproteins (23) in the ER. Calnexin associates with 
free class I HCs soon after their synthesis, but this associa- 
tion is transient and calnexin dissociates from completely as- 
sembled class I complexes  (24, 25). Thus, calnexin has been 
hypothesized to play a role in facilitating class I assembly and 
in mediating retention of incompletely assembled complexes 
in the ER (26,  27). 
In the present study, we characterize a pool of calnexin- 
associated class I HCs, and delineate a possible  stepwise  se- 
quence of class I assembly. 
Materials and Methods 
Cells, Antibodies, andPeptides.  T2 and T1 cell lines (28) and T2 
cells transfected with HLA-B27 (T2/B27) (13) were provided by 
Dr. Peter Cresswell (Yale University, New Haven, CT). These ceil 
lines were cultured in RPMI 1640 (GIBCO BRL, Gaithersburg, 
MD)  supplemented with  10%  heat-inactivated FCS  (Hyclone 
Laboratories, Logan, UT), 20 mM Hepes, 2 mM glutamine, and 
1 mM pyruvate (all from GIBCO BILL) at 37~  in a 5% CO2 
atmosphere. B2m-deficient  FO-1 cells (29) were provided by Dr. 
Soldano Ferrone (New York Medical Coflege, Valhalla, NY). 3zm- 
expressing and mock transfectant clones of FO-1 cells were ob- 
tained from transfection of  either pb2m13 (30) plus pSRoe-neo (31) 
or pSRot-neo alone, respectively,  by calcium phosphate precipita- 
tion method (32). These transfectant  clones  were grown in DMEM 
supplemented with 10% FCS in the presence of 0.5 rag/m1 G418 
(Geneticin; Sigma Chemical Co., St. Louis, MO). mAbs W6/32 
(specific for 32m +  :HC; IgG2a) (33), L243 (anti-HLA-DR anti- 
body;  IgG2a) (34), and P3  (negative control;  IgG1) (35) were 
obtained from the American Type Culture Coflection (Rockville, 
MD). mAb HC-10 (IgG2a) which recognizes B2m-  :HC, but not 
Bzm  +  :HC (36) was provided by Dr. Hidde Ploegh (Massachusetts 
Institute of  Technology,  Cambridge, MA). Anti-calnexin/IP90 an- 
tibody, AF8 (IgG1), was generated in our laboratory (20). UPC10 
is a negative  control antibody (IgG2a) purchased from Sigma  Chem- 
ical Co. M57-68K62 peptide (14) which binds to HLA-A2.1 was 
synthesized  with a peptide synthesizer (model 430A; Applied Bio- 
systems Inc., Foster City, CA) at the core biopolymer laboratory, 
Brigham and Women's  Hospital. HLA-B27-restricted  B27NP pep- 
tide (18) was a gift from Dr. William E. Biddison (National Insti- 
tutes of Health, Bethesda, MD). 
Intracelhlar Iodination.  Intracellular iodination was performed 
as described (20). Briefly, T2 cells (4  x  107) were permeabilized 
in 8 pM digitonin (Aldrich Chemical Co., Milwaukee, WI) for 
5 min. After lactoperoxidase-mediated  iodination of  permeabilized 
T2 cells, they  were sohbilized  in 1% digitonin  in lysis  buffer  (140 mM 
NaC1, 50 mM Tris (pH 7.6), 7.5 mM iodoacetamide, and 1 mM 
PMSF). Immunoprecipitations  with indicated mAbs were analyzed 
on a SDS-PAGE gel under reducing conditions and visualized by 
autoradiography on Kodak XAR film. 
In Vitro Peptide-dependent  Assembly.  After 1 h preincubation in 
methionine-free RPMI 1640 media, 107 cells/ml were labeled for 
5 min with 0.2 mCi [3SS]methionine  (NEG-072 EXPRE3ZS32S; Du 
Pont Co., Boston, MA). Cells were lysed in 0.5% Triton X-100 
in lysis buffer either in the presence or absence ofpeptides. After 
20 rain at 4~  the nuclei were removed  by centrifugation and the 
lysates were precleared overnight at 4~  with Staphylococcus aureus 
Cowan strain I (Pansorbin; Calbiochem-Novabiochem  Corp., La 
Jolla, CA). Assembled class I molecules were detected with 1 pl 
of mAb W6/32 ascites, followed  by immunoprecipitation with 50 
/zl of 10% protein A-Sepharose CD4B (Pharmacia, Piscataway,  NJ). 
Pellets were washed four times with 0.5% Triton X-100 in Tris- 
buffered saline. The samples were analyzed on a SDS-PAGE gel 
under reducing conditions or, in some experiments, on IEF/SDS- 
PAGE two-dimensional gels as described (21). The  gels were 
fluorographed using PPO(2.5-diphenyloxazole)-DMSO  (Du Pont 
Co.), dried, and exposed to Kodak XAR film. 
Rapid Immunoprecipitation.  T1 and T2 cells were biosyntheti- 
cally labeled with [3SS]methionine for 5 min as described above. 
Cells were then solubilized in 0.5% Triton X-100 in lysis buffer 
containing mAb  UPC10 (2 /~g/ml), mAbs W6/32,  or HC10 
(1:1,000 dilution of ascites). After 15 min at 4~  the nuclei were 
removed  by centrifugation and the lysates  were incubated with pro- 
tein A-Sepharose CI.-4B (Pharmacia) for 30 min. The beads were 
washed four times with 0.1% Triton X-100 in Tris-buffered saline 
and boiled in sample buffer. All the procedures before electropho- 
resis were completed at 4~  within 2 h. 
Pulse Chase Experiments.  Pulse  chase experiments were per- 
formed as described (21) with slight modifications. Cells pulse la- 
baled with [3SS]methionine  for 5 min were washed in PBS and in- 
cubated at 37~  in complete RPMI 1640 media/10X methionine/ 
10X cysteine  supphmented with 10% heat-inactivated  FCS for in- 
dicated periods of time. The calls were harvested and washed in 
PBS, and lysed  in 0.5% Triton X-100 or 0.3% CHAPS 3-([3-chola- 
midoproFyl]-dimethylammonio)-l-propane-sulfonate  in lysis  buffer, 
followed by the same immunoprecipitation procedure described 
above (see in vitro peptide dependent assembly). Counts per minute 
of calnexin molecules (cpmcNx) immunoprecipitated with mAb 
AF8 and counts per minute of class I HCs (cpm.c) coimmuno- 
precipitated with mAb AF8 were counted directly by a blot ana- 
lyzer (Betascope 603; Betagen Corp., Waltham, MA) by gating 
on the regions of 90 kD and 42-43 kD respectively, in the same 
lane. Background counts per minute (cpmsG) was also counted 
from a separate site at the same position on each lane of the gels. 
To evaluate the relative amount of calnexin-associated  class I HCs, 
an association index was calculated as follows: association index 
=  (cpm.c  -  cpmBG)/(cpmcNx --  cpmBG). 
l~suhs 
l~2ra-free  Class  I  HCs  (fl2m-:HC)  Are  Associated with 
Calinexin  in  T2  Cells.  We previously demonstrated that 
Bzm-:HC,  which are  recognized by mAb HC10,  are  as- 
sociated with calnexin in fl2m-deficient Daudi calls (20). To 
examine whether 32m- :HC also were bound to calnexin in 
peptide transporter-deficient  T2 cells, we carried out iodination 
of intraceUuhr proteins using a permeabilized ceU iodination 
technique. As an abundant ER protein, calnexin was visual- 
ized prominently by this method (Fig. 1, lane 2). The HC10 
antibody coimmunopt~zipitated calnexin with B2m-:HC 
from iodinated T2 calls (Fig.  1, lane 3), demonstrating the 
association of calnexin with class I HCs that had not assem- 
bled with B2m. Note that in contrast to the HC10 antibody, 
a comformation-dependent antibody, W6/32, which recog- 
nizes  32m+:HC,  failed  to  coimmunoprecipitate calnexin 
(Fig. 1, lane 4). This implied that calnexin bound B2m- :HC, 
but not 32m + :HC. This led us to assume that there may 
be several distinct intraceUular  class I HC pools, including 
B2m-unassociated HCs (B2m  +  :HC) either bound to calnexin 
or not,  and B2m-associated HCs (32m +  :HC)  which may 
contain a bound peptide (32m +  :HC:pep +) or not (32m+: 
HC:pep-)  (Fig.  2). 
The  32m-:HC  pool  associated  with calnexin was  not 
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meabilized  T2 cells were iodinated  and lysed  in 1% digitonin.  Immuno- 
precipitation  was performed  with mAbs  P3 (control),  AF8 (anticalnexin), 
HCIO (anti-Bzm-  :HC), and W6/32 (anti-~zm  +  :HC), followed  by reso- 
lution on a SDS-PAGE  gel under  reducing  conditions.  (Right) The posi- 
tions of calnexin, MHC class I HC (HC), and ~2m. 
readily visualized  by iodination (Fig.  1, lane 2).  This pool 
was more efficiently identified by coimmunoprecipitation  with 
calnexin when T2 cells were pulse-labeled  biosynthetically 
with [3SS]methionine for 5 min. mAb AF8 immunoprecip- 
itated calnexin (Fig. 3 A, lane 1, arrow), and also coimmuno- 
precipitated a number of other proteins. A band was observed 
in lane I  (arrowhead) that comigrated with class I HCs im- 
munoprecipitated  with mAb HC10 (lane 2). It was confirmed 
by IEF/SDS-PAGE  two-dimensional gel analysis that most 
of the proteins contained in this band were mAb HC10-reactive 
class I HCs (Fig. 3 B).  The efficient visualization of dass I 
HCs associated  with calnexin by biosynthetically pulse labeling 
cells implied that calnexin bound preferentially  newly syn- 
thesized class I HCs.  However,  in the reciprocal  immuno- 
precipitation the calnexin band was faintly visualized in the 
immunoprecipitation with mAb HC10 (Fig. 3 A, lane 2), 
since in this 5-rain biosynthetic labeling only a small frac- 
tion of calnexin molecules, which have a half-life of >24 h 
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(data  not  shown), were labeled.  We infer that  the major 
portion of 32m- :HC-associated calnexin molecules are from 
a pool of preexisting, unlabeled calnexin molecules, since 
32m-:HC-associated calnexin molecules were  readily  de- 
tected after permeabilized iodination which labels all calnexin 
molecules (Fig. 1, lane 3). Thus, both biosynthetic and radio- 
iodination techniques revealed the association of calnexin with 
/32m- :HC. However, neither technique revealed a detectable 
association of calnexin with assembled class I molecules rec- 
ognized by the comformation-dependent mAb W6/32. 
Calnexin-associated Class I HCs do not Appear to be the Im- 
mediate Precurso~  for Peptide-Dependent Class I Assembly.  Town- 
send and co-workers (14-16,  37)  have shown that class I 
assembly can be induced in vitro in lysates of peptide trans- 
porter-deficient cells by the addition of specific peptides. In 
this study we used T2/B27 cells, which synthesize both en- 
dogenous HLA-A2  and  transfected  HLA-B27  HCs.  Em- 
ploying T2/B27 cells made it possible to obtain substantial 
assembled  class  I  molecules by taking advantage of both 
HLA-A2  and -B27  alleles for which specific peptides are 
known.  The cells were labeled  with  [3SS]methionine for 
5 min, and lysed in 0.5% Triton X-100 in the presence or 
absence of a mixture of HLA-A2-restricted peptide (M57- 
68K62)  and  HLA-B27-restricted  peptide (B27NP).  mAb 
W6/32 detected substantial class I complexes after the addi- 
tion of the mixture of HLA-A2 and -B27 restricted peptides, 
as compared with that seen in their absence (Fig. 3 A, com- 
pare lanes 3 and 6). The faint but significant immunoprecip- 
itation of class I HCs with mAb W6/32 in the absence of 
peptides (Fig. 3 A, lane 3) may be due either to assembled 
t-ILA-A2 molecules which bound peptides derived from signal 
sequences (38, 39) or to a small quantity of/32m  +  :HC:pep- 
complexes. 
Despite the abundant appearance of W6/32 reactive class 
I complexes (Fig.  3 A, lane 6),  neither the HC10-reactive 
B2m-:HC pool (lanes 2 and 5) nor the calnexin-associated 
~2m- :HC pool of class I molecules (lanes I  and 4) appeared 
to diminish after the addition of peptides. The absence of 
change in these B2m- :HC pools by the addition of peptides 
led us to speculate  that in this in vitro peptide-dependent 
assembly  system,  ~2m-:HC,  either bound to calnexin or 
not, were not the direct precursors  of the class I complexes 
being assembled. 
Unstable ~2m +  :HC:pep -  Complexes Are Present in T1 and 
T2 Cells.  Several  studies have shown that in this in vitro 
peptide-dependent class I assembly system, unstable ~2m +  : 
HC:pep- complexes could be stabilized in detergent by the 
addition of specific peptide (14, 15, 37, 40).  We confirmed 
the presence of these unstable complexes in mutant T2 cells 
and wild-type T1 cells by comparing rapid immunoprecipi- 
ration with regular immunoprecipitation (see Materials  and 
Methods). With the rapid immunoprecipitation method, a 
large pool of W6/32-reactive, B2m  +  :HC complexes could 
be detected even without the addition of peptide in peptide- 
deficient T2 cells (Fig. 4, lane 8). On the other hand, when 
exactly the same procedure was carried out, except that mAb 
W6/32 was added after overnight incubation of the lysate 
at  4~  remarkably fewer/32m+:HC complexes were de- ~2m-unassociated HC 
([B2m--HC) 
\ 
calnexin-associated  HC 
/ 
recognized by mAb HC10 
pep O 
~2m-associated HC 
that are peptide-free 
~ 
2m+:HC:pep  ") 
completed complexes 
([32m+:HC:pep  "1") 
/ 
recognized by mAb W6/32 
Figure 2.  Four distinct pools of 
class I HC, distinguished by immu- 
noprecipitation  with mAbs HC10 
and W6/32 which recognize 3zm- 
free and ,$2m-associat~  class I HCs, 
respectively. 
Figure 3.  ~2m-:HC pools  are 
unaffected  by peptide-dependent as- 
sembly of MHC class I molecules 
in T2 cell lysates. (A) T2/B27 cells 
were radiolabeled with [3sS]methi- 
onine for 5 min and lysed in 0.5% 
Triton X-100 either in the absence 
(lanes I-3) or presence of a mixture 
of 50/~M M57-68K62 and 5/xM 
B27NP  peptides  (lanes 4-6).  Im- 
munoprecipitations  were carried out 
with the antibodies indicated,, fol- 
lowed by resolution on a SDS-PAGE 
gel under reducing conditions. The 
position of the MHC class I HC is 
shown to  the right.  (B) T2/B27 
cells were metabolically  labeled  with 
[3sS]methionine for 5 rain, solubi- 
lized in 0.5% Triton X-100, and im- 
munoprecipitated  with mAbs HC10 
and AF8. Immunoprecipitates were 
resolved on two-dimensional  gels 
(IEF followed  by SDS-PAGE).  Solid 
arrows identify calnexin. 
2166  Role of Calnexin in MHC Class I Assembly Figure  4.  Differences in B2m + :HC and B2m - :HC pools are detected 
based on cell type and time after detergent lysis. T1 (lanes I-6) and T2 
(lanes 7-I2) cells were radiolabded with [3sS]methionine for 5 min. Cells 
were divided equally into six aliquots and three of them were used for 
rapid immunoprecipitation (rapid IP)  (see Materials  and Methods, lanes 
I-3 and 7-9). Lysates from the remaining three were incubated overnight 
at 4~  and immunopreeipitation was performed on the following day 
(regular IF'). UPC10 is an isotype-matched (IgG2a) negative control anti- 
body The samples were analysed on a SDS-PAGE gel under reducing con- 
ditions. (Right)  The positions of the class I HC and fl2m. 
tected by the antibody (Fig. 4, lane 11). Correspondingly, 
more ~/2m- :HC was detected with mAb HC10 than in the 
rapid immunoprecipitation. Since these experiments were per- 
formed in the absence of added peptides, we concluded that 
a substantial pool of j82m  +  :HC:pep- complexes were gener- 
ated in T2 cells and were recognized by mAb W6/32, but 
that these complexes were unstable and presumably disassem- 
bled during the overnight incubation at 4~ 
Wild-type T1 cells, which have not deleted the TAP.1 and 
TAP.2 genes, have apparently normal class I assembly. Un- 
like T2 cell lysates, T1 cell lysates, which contain a substan- 
tial  pool  of completely asgembled class I  molecules,  still 
contained substantial quantities of  W6/32-reactive class I mol- 
ecules after overnight incubation (Fig. 4, lane 5). However, 
a  significant  reduction in  ~2m-:HC  immunoprecipitated 
with mAb W6/32 and an increase in ~/2m-:HC immuno- 
precipitated with mAb HC10 were observed after overnight 
incubation even in T1 cells (Fig. 4, compare lanes 2 and 5, 
and lanes 3 and 6). Since a greater quantity of  W6/32-reactive 
class I molecules were detected by rapid immunoprecipita- 
tion compared to after an overnight incubation, we concluded 
that relatively unstable B2m +  :HC complexes were generated 
not only in peptide transporter deficient mutant cells  but also 
in normal cells, as suggested by others (14, 15, 40). 
/32m, But Not Peptide, Controls Dissociation of Class I HCs 
from Calnexin.  The in vitro results shown above suggested 
that a cahaexin-unassodated  32m +  :HC:pep- complex capable 
of  binding peptide existed and raised the possibility that class 
I HCs may dissociate from calnexin before peptide binding. 
If correct, then the dissociation rate of class I HCs from cal- 
nexin in vivo would be expected to be similar in T1 and T2 
cells. To test this possibility, we carried out a pulse chase ex- 
periment of the two cell lines (Fig. 5 A). As expected, in 
T1 cells, the HC10-reactive 32m-:HC pool decreased and 
a large amount of  W6/32-reactive class I molecules were de- 
tected during a chase period, consistent with normal MHC 
class I assembly. In contrast,  in T2 cells the total  amount 
of 32m-:HC pool remained almost unchanged during the 
chase period and a much smaller amount of assembled class 
I molecules were observed, consistent  with a deficiency in 
peptides in the ER lumen of these cells. It is important to 
note that the association of  class I HCs with calnexin dimin- 
ished during the chase period of time in both T1  and T2 
cells, and that the rate of dissociation was almost indistin- 
guishable between the two call lines despite the difference 
in availability of peptides in the ER of these two cell lines 
(Fig.  5 C,  left). 
To address the possibility that B2m controls  the rates of 
dissociation  of class I  HCs  from calnexin,  we examined 
32m + and 32m-  cells. For comparison  with 32m-deficient 
FO-1 cells (FO-1 mock), we transfected the 32m genomic 
DNA clone and reconstituted 32m expression in FO1 cells 
(FO-1  32m).  In  contrast  to  the  observation  of peptide- 
deficient cells above, a significant difference in dissociation 
of class I HCs from calnexin in vivo was found between 
~2m-deficient FO-1  mock and ~2m-expressing FO-1  32m 
cells. In FO-1  ~82m cells, a decrease in the HC10-reactive 
B2m-:HC pool and the appearance of the W6/32-reactive 
B2m+:HC  pool  was  observed  during  the  chase  period, 
whereas in ~2m-deficient FO-1 mock cells, the total amount 
of/32m-:HC pool remained almost unchanged and no ap- 
pearance of the W6/32-reactive ~/2m+:HC pool was seen 
(Fig. 5 B). More importantly, the association of class I HCs 
with calnexin diminished during the chase period in FO-1 
B2m cells, whereas class I HCs remained associated with cal- 
nexin in the A82m-deficient  FO-1 mock cells (Fig.  5, B and 
C,  right). 
Discussion 
In order for class I molecules to complete their assembly 
and exit the ER,  at least three events should  take place in 
the ER; namely, binding of Barn to class I HC, binding of 
peptide to class I HC, and dissociation of class I HC from 
calnexin. The former two are critically important for proper 
expression of class I molecules because lack of either 32m 
or peptide has been shown to result in severely  impaired class 
I expression (7-11). Properly regulated dissociation of class 
I HCs from calnexin seems also essential since class I HCs 
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Figure 5.  The rates of dissociation of MHC class 
I HCs from calnexin are similar in peptide trans- 
porter-deficient  T2 cells and wild-type T1  cells, 
whereas  they  differ between ~2m-deficient FO-1 
mock and 32m-expressing FO-1 32m ceils. (.4 and 
B) T1 and T2 cells (A) or FO-1 mock and FO-1 
/~2m cells (B) were radiolabeled with [3sSlmethio- 
nine for 5 min and chased for indicated periods of 
time. Ceils were harvested and lysed in 0.5% Triton 
X-100. The lysates were equally aliquoted, and im- 
munoprecipitation was performed with indicated an- 
tibodies. The samples were analysed on SDS-PAGE 
gels under reducing conditions. Immunoprecipita- 
tion with mAb P3 (negative control) did not show 
any appreciable background (data not shown). The 
positions of calnexin and the class I HC are indi- 
cated with an arrow and arrowheads, respectively. 
(C) An association index at each chase period was 
calculated  as described in Materials and Methods and 
plotted. 
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Figure 6.  Schematic  model  of 
class I assembly. (HC) Class I HC; 
(B~'n) 3rmicroglobulin; (P) pepticle. 
are retained in the ER by calnexin in the absence of 32m 
(24,  41). In the present study, we describe the stepwise se- 
quence of these events. 
One of the important approaches of this study was to dis- 
criminate intracellular class I HC pools in terms of associa- 
tion either with ~32m or with calnexin and to assess changes 
in these pools during peptide-dependent class I assembly (or 
stabilization) in cell lysates. The interaction of nascent class 
I HCs with calnexin occurs very soon after their synthesis 
(possibly cotranslationally or cotranslocationally) (21,  22). 
Thus, employing 5 min short pulse labeling with [3SS]me- 
thionine made it  possible to visualize a pool of calnexin- 
associated class I HCs in immunoprecipitates with an anti- 
calnexin antibody (Fig.  3 A, lane 1).  Class  I HCs in this 
pool appeared to  be  /52m-unassociated  since calnexin was 
coimmunoprecipitated with mAb HC10, which recognizes 
32m-:HC, but not with W6/32,  which recognizes 32m+: 
HC (Fig.  1). 
The addition of specific peptides upon lysis of peptide trans- 
porter-deficient cell lines has been shown to stabilize 32m + : 
HC:pep-  in detergent (14, 15, 37, 40), which is manifested 
by an increase in the amount of 32m + :HC immunoprecipi- 
tated. In our experiments, we used T2/B27 cells expressing 
both endogenous HLA-A2 and transfected -B27 HCs.  As 
expected, the addition of HLA-A2 and -B27 restricted pep- 
tides resulted in a significant increase in W6/32-reactive class 
I HC complexes (Fig.  3, lane 6).  However, the detectable 
pool of calnexin-associated class I  HCs  did not appear to 
diminish despite the abundant appearance of assembled class 
I complexes (Fig. 3). This is consistent with the above obser- 
vation that calnexin-bound class I HCs are unassociated with 
32m since these peptide addition experiments preferentially 
detect stabilizing effect of peptide on unstable 32m + :HC: 
pep-  complexes. 
The presence of unstable B2m + :HC:pep- complexes which 
are not bound to calnexin in normal cells and the finding 
that calnexin binds 32m-:HC led us to speculate that the 
dissociation of class I HCs from calnexin might be controlled 
by binding of ~2m. Previous work has implied that newly 
synthesized class I HCs are retained for a prolonged period 
of time in association with calnexin in 32m-deficient Daudi 
cells (24, 41), which implied a requirement for 32m for the 
dissociation of class I HCs from calnexin. We confirmed this 
by comparing 32m-deficient FO-1  cells,  which  showed a 
prolonged association of class I  HCs with calnexin, with 
32m transfected FO-1 cells, which displayed more rapid dis- 
sociation of class I HCs from calnexin (Fig. 5 B). In contrast, 
class I HCs did not show a prolonged association with cal- 
nexin in T2 cells in which peptides are not available but 32m 
is present (Fig.  5 A). Class I HCs dissociated from calnexin 
in T2 cells at a similar rate as in wild-type T1 cells (Fig.  5 
C), implying that peptide binding was not required for class 
I  HCs  to dissociate from calnexin.  These conclusions are 
strengthened by the recent demonstration that calnexin-free 
32m+:HC:pep -  complexes physically associate  with  TAP 
molecules in human (42). These results are in contrast with 
studies of mouse p88/calnexin, in which a requirement for 
both 32m and peptide for the dissociation of class I HCs 
from calnexin was detected (24) and murine 32m + :HC:pep- 
complexes were efficiently retained by p88/calnexin when ex- 
pressed in Drosophila cells (26). Although the reason for this 
apparent disparity is not known, the difference might be ex- 
plained by variable behavior of subtypes of class I molecules 
from the different species examined. Species-specific differ- 
ences in MHC class I assembly and transport have been noted 
previously,  as in the report that mouse class I molecules ex- 
pressed in RMA-S and T2 cells behave differently from human 
class I molecules in these cell lines, presumably due to fun- 
damental structural differences of the class I glycoproteins 
between species (43). 
From the observations above, we propose an in vivo pathway 
for class I assembly (Fig.  6). Newly synthesized class I HCs 
bind to calnexin which retains them in the ER (HC-calnexin). 
Subsequently, the association of 32m occurs to form a tran- 
sient trimolecular complex of HC, 32m, and calnexin (shown 
within parentheses).  Calnexin then dissociates  from 32m- 
associated  HCs (HC-32m) and finally,  these unstable pep- 
tide-free class I complexes bind peptide to complete the as- 
sembly process and stabilize the MHC class I complexes. Thus, 
calnexin mediates retention of the ~2m-unassociated class I 
HCs and dimerization of class I  HCs with B2m,  and the 
final step of peptide loading onto 32m + :HC:pep- complexes 
may be facilitated by physical association of these class I com- 
plexes with TAP molecules, as suggested by Cresswell and 
colleagues (42).  It remains to be clarified if TAP molecules 
exist in close approximation to calnexin and by what mecha- 
nisms 32m + :HC:pep-  complexes can bind to and dissociate 
from TAP molecules. 
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